CSIMarket Company Name, Ticker, Competitors, else..
 
Vistagen Therapeutics Inc   (VTGN)
Other Ticker:  
 
 

Vistagen Therapeutics Inc Balance Sheet Annual

VTGN


Select the Financial Report:   Period:   Fiscal Year:




New: More VTGN's historic Annual Balance Sheets >>

VTGN Balance Sheets
(Annual, GAAP in millions $)

 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020
ASSETS
Cash & cash equivalent 119.17 16.64 68.14 103.11 1.36
Cash, Cash Eqvivalents Other - - - - -
Cash & Short-term Investments 119.17 16.64 68.14 103.11 1.36
Accounts receivable - - - - -
Other Receivables, Net, Current - - - 0.04 -
Notes Receivable, Current - - - - -
Inventories - - - - -
Deferred Costs, Current AS 0.07 0.07 0.12 0.13 0.36
Prepaid Expense And Other Assets Current 1.43 0.80 2.75 0.84 0.23
Total Current Assets 120.67 17.51 71.00 104.12 1.94
Equipment/Property/Plant Net 0.44 0.51 0.41 0.37 0.21
Goodwill net - - - - -
Intangible Assets - - - - -
Long-term investments - - - - -
Accounts Receivable, Net, Noncurrent - - - - -
Deposits Assets, Noncurrent AS 0.10 0.10 0.10 - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 2.32 2.76 2.98 3.56 3.63
Deferred Costs, Noncurrent AS 0.13 0.22 0.15 0.23 -
Discontinued operations, Noncurrent - - - - -
Total Assets 123.65 21.09 74.64 108.28 5.77
LIABILITIES
Accounts Payable, Current AC 1.55 2.47 2.76 0.84 1.84
Accrued Liabilities, Current AC 2.24 0.79 1.33 1.56 0.56
Financial Instruments - - - - -
Notes Payable, Current NO - 0.11 - - 0.06
Other Liabilities, Current 1.34 1.20 1.68 0.37 0.32
Taxes Payable - - - - -
Deferred Revenue, Current DE - - - 1.42 -
Discontinued Operation, Liabilities, Current - - - - -
Notes Payable And Accrued Interest To Related Parties - - - - -
Put Option And Note Term Extension Option Liabilities - - - - -
Total Current Liabilities 5.12 4.57 5.77 4.19 2.77
Long-term debt - - - - -
Capital Lease Obligations, Noncurrent LO - - - - -
Long-term Debt Convertible - - - - -
Total Long-term Debt - - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred Revenue, Noncurrent DE - - - 2.49 -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent 4.24 4.44 4.16 9.62 8.73
Total Liabilities 9.37 9.01 9.93 16.30 11.50
SHAREHOLDER'S EQUITY
Common Stock Value 0.03 0.01 0.21 0.18 0.05
Treasury Stock Value - - -3.97 -3.97 -3.97
Additional Paid In Capital Common Stock 474.44 342.89 336.08 315.60 200.09
Retained Earnings / Accumulated Deficit -356.21 -326.85 -267.60 -219.84 -201.91
Other Equity -3.97 -3.97 0.00 0.00 0.00
Common Stockholder's Equity 114.29 12.08 64.72 91.98 -5.73
Preferred Stockholder's Equity - - - 0.00 0.00
Noncontrolling interests & other - - - - -
Total Stockholder's Equity 114.29 12.08 64.72 91.98 -5.73
Liabilities & Stockholder's Equity 123.65 21.09 74.64 108.28 5.77






Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com